MMP9 - matrix metallopeptidase 9 Gene
Species: Bos taurus
Gene Type: protein coding
Gene ID: 282871
About MMP9
Primary_assembly 13: 74,746,976-74,754,303 forward strand.ARS-UCD1.2:CM008180.2
This gene has 1 transcript (splice variant), 216 orthologues and 21 paralogues.
MMP9 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_174744.2 | NP_777169.1 | matrix metalloproteinase-9 precursor |
MMP9 Protein Structure
PG_binding_1
PG_binding_1: pfam01471 (39 - 93)
Peptidase_M10
Peptidase_M10: pfam00413 (114 - 443)
FN2
FN2: smart00059 (222 - 270)
FN2
FN2: smart00059 (280 - 328)
FN2
FN2: smart00059 (339 - 387)
HX
HX: cd00094 (518 - 708)
- 0
- 200
- 400
- 600
- 712 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
matrix metalloproteinase-9 |
|
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(17)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0099 | Edaravone | 99.94% | Yes | |
| HY-B0633A | Hyaluronic acid | Activator | / | Yes |
| HY-B0633 | Hyaluronic acid sodium | Activator | 98.0% | Unkown |
| HY-12723 | Apomorphine | 99.48% | Unkown | |
| HY-B0493 | Niflumic acid | Inhibitor | 99.61% | Unkown |
| HY-B0012 | Pamidronic acid | Inhibitor | 99.05% | Yes |
| HY-B0012A | Pamidronate disodium | Inhibitor | 98.0% | Yes |
| HY-14744A | Levamlodipine besylate | Inhibitor | 99.84% | Unkown |
| HY-90003 | Tianeptine | 99.84% | Unkown | |
| HY-B0730 | Pamidronate disodium pentahydrate | 98.0% | Unkown | |
| HY-14744 | Levamlodipine | Inhibitor | 98.06% | Unkown |
| HY-90003A | Tianeptine sodium salt | 99.90% | Unkown | |
| HY-B1451A | Imidapril | Inhibitor | 99.0% | Yes |
| HY-B0493R | Niflumic acid (Standard) | Inhibitor | 99.93% | Unkown |
| HY-B1451 | Imidapril hydrochloride | Inhibitor | 99.91% | Yes |
| HY-12723R | Apomorphine (Standard) | / | Unkown | |
| HY-90003AR | Tianeptine sodium salt (Standard) | / | Unkown |
Clinical Phase
Bioactive Molecules
(11)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-B0012B | Pamidronic acid sodium | Inhibitor | / | Phase 4 |
| HY-12169 | Marimastat | Inhibitor | 99.81% | Phase 3 |
| HY-12170 | Prinomastat | 98.41% | Phase 3 | |
| HY-12170A | Prinomastat hydrochloride | 98.53% | Phase 3 | |
| HY-121872 | DP-b99 | Inhibitor | 95.0% | Phase 3 |
| HY-15768 | Ilomastat | Inhibitor | 99.14% | Phase 2 |
| HY-107581 | MK-1903 | 99.68% | Phase 2 | |
| HY-106992 | S 3304 | Inhibitor | 99.75% | Phase 2 |
| HY-101276 | AZD-1236 | Inhibitor | 99.62% | Phase 2 |
| HY-112160 | XL-784 free base | Inhibitor | / | Phase 2 |
| HY-114214 | CKD-712 | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99351 | Andecaliximab | Inhibitor | 98.57% | Phase 3 |
| HY-P991419 | MSB-0254 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(195)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0431 | Astragaloside IV | Inhibitor | 99.93% | Unkown |
| HY-19956 | GI254023X | Inhibitor | 99.67% | Unkown |
| HY-N2117 | Isoginkgetin | 99.91% | Unkown | |
| HY-13564 | Batimastat | Inhibitor | 98.92% | Unkown |
| HY-N0318 | Salvianolic acid A | 99.72% | Unkown | |
| HY-12354 | SB-3CT | Inhibitor | 99.84% | Unkown |
| HY-W016562 | Hippuric acid | 99.98% | Unkown | |
| HY-135232 | MMP-9-IN-1 | Inhibitor | 99.82% | Unkown |
| HY-110397 | KP-457 | Inhibitor | 99.18% | Unkown |
| HY-113952 | Actinonin | 98.37% | Unkown | |
| HY-E70005C | Collagenase, Type III | / | Unkown | |
| HY-N0069 | Solamargine | 99.87% | Unkown | |
| HY-103482 | JNJ0966 | Inhibitor | 99.80% | Unkown |
| HY-103444 | ARP-100 | Inhibitor | ≥99.0% | Unkown |
| HY-N1454 | Apigenin-7-glucuronide | Inhibitor | 99.74% | Unkown |
| HY-N1463 | Luteolin 7-O-glucuronide | Inhibitor | 99.98% | Unkown |
| HY-108527 | CD1530 | 98.01% | Unkown | |
| HY-P2036A | FSL-1 TFA | 99.81% | Unkown | |
| HY-P4373A | Hepcidin-1 (mouse) TFA | Inducer | 98.86% | Unkown |
| HY-159059 | Ganoderma Lucidum/Reishi Extract | 41.20% | Unkown | |
| HY-W016412 | Coenzyme Q0 | 99.79% | Unkown | |
| HY-107394 | UK 356618 | Inhibitor | 98.91% | Unkown |
| HY-124373 | ND-336 | Inhibitor | 97.16% | Unkown |
| HY-N3945 | Glaucine | 99.57% | Unkown | |
| HY-N1508 | Ecliptasaponin A | 99.81% | Unkown | |
| HY-P2179 | MMP-1/MMP-9 Substrate, Fluorogenic | 98.83% | Unkown | |
| HY-N2374 | Eupatorin | Inhibitor | 99.53% | Unkown |
| HY-N6983 | Licoricesaponin G2 | 99.87% | Unkown | |
| HY-B0633D | Hyaluronic acid sodium (MW 200-1560) | 99.41% | Unkown | |
| HY-W004486 | Gallic aldehyde | Inhibitor | 99.92% | Unkown |
| HY-W014841 | Sodium hippurate, 98% | 99.91% | Unkown | |
| HY-12964 | SGI-7079 | Inhibitor | 99.32% | Unkown |
| HY-119423 | MMP Inhibitor II | Inhibitor | 99.7% | Unkown |
| HY-162038 | RXP03 | Inhibitor | 98.82% | Unkown |
| HY-B0633I | Hyaluronic acid sodium (MW 800kDa) | / | Unkown | |
| HY-N0084 | Betulinaldehyde | Inhibitor | 98.72% | Unkown |
| HY-116626 | SM-7368 | Inhibitor | 99.77% | Unkown |
| HY-124813 | PDZ1i | Inhibitor | 99.29% | Unkown |
| HY-N2132 | Flavokawain B | 99.99% | Unkown | |
| HY-P3513 | β-Neo-Endorphin | Activator | 98.97% | Unkown |
| HY-N2497 | Isoliquiritin apioside | Inhibitor | 99.87% | Unkown |
| HY-116302 | MMP-9-IN-9 | Inhibitor | 99.26% | Unkown |
| HY-107639 | UK-370106 | Inhibitor | ≥99.0% | Unkown |
| HY-128026 | MMP-9/MMP-13 Inhibitor I | Inhibitor | 99.68% | Unkown |
| HY-161285 | MMP-9/10-IN-2 | Inhibitor | 99.87% | Unkown |
| HY-N0757 | 8-O-Acetylharpagide | 99.75% | Unkown | |
| HY-116399 | MMP-2/MMP-9-IN-1 | Inhibitor | 99.48% | Unkown |
| HY-116474 | Viridicatol | 99.93% | Unkown | |
| HY-12168 | Tanomastat | Inhibitor | 99.74% | Unkown |
| HY-117970 | MMPI-1154 | Inhibitor | 99.76% | Unkown |
| HY-N1401 | 20(R)-Ginsenoside Rh2 | 99.84% | Unkown | |
| HY-W001925 | 7-Methoxy-1-tetralone | 99.93% | Unkown | |
| HY-110397G | KP-457 (GMP) | Inhibitor | / | Unkown |
| HY-120213 | YH-306 | 98.34% | Unkown | |
| HY-125847 | Salvianolic acid F | 99.50% | Unkown | |
| HY-19485 | XL-784 | Inhibitor | 98.25% | Unkown |
| HY-W011085 | CP-471474 | Inhibitor | 99.2% | Unkown |
| HY-114091 | PF-00356231 hydrochloride | Inhibitor | 99.52% | Unkown |
| HY-125864B | Murine Fibrinogen | / | Unkown | |
| HY-114785 | BPHA | Inhibitor | 99.88% | Unkown |
| HY-176184 | PROTAC DDR1 degrader-1 | 98.69% | Unkown | |
| HY-N5136 | 25(R,S)-Ruscogenin | Inhibitor | 99.83% | Unkown |
| HY-N6896 | Isoviolanthin | Inhibitor | 99.87% | Unkown |
| HY-P10143 | MMP-2/MMP-9 Substrate | Substrate | 98.48% | Unkown |
| HY-P3484 | Dnp-PLGLWA-DArg-NH2 TFA | 99.78% | Unkown | |
| HY-111186 | Flocoumafen | Inhibitor | 99.35% | Unkown |
| HY-114911 | Feprazone | Inhibitor | 99.88% | Unkown |
| HY-119979 | Cardanol monoene | Inducer | 98.02% | Unkown |
| HY-147745 | MMP2-IN-2 | Inhibitor | 98.80% | Unkown |
| HY-181654 | Snail IN-1 | Inhibitor | 98.27% | Unkown |
| HY-B0633E | Hyaluronic acid, low endotoxin | / | Unkown | |
| HY-N6862 | Lucideric acid A | Inhibitor | 98.44% | Unkown |
| HY-N7385 | Nudol | 99.60% | Unkown | |
| HY-P0273A | Histatin 5 TFA | Inhibitor | 99.98% | Unkown |
| HY-P4905 | Mca-Pro-Leu-Gly-Leu-Glu-Glu-Ala-Dap(Dnp)-NH2 | Inhibitor | 98.02% | Unkown |
| HY-13564A | Batimastat sodium salt | Inhibitor | 99.04% | Unkown |
| HY-RS08557 | MMP9 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-RS08558 | Mmp9 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-110116 | SD-2590 hydrochloride | Inhibitor | 99.4% | Unkown |
| HY-131417 | cis-ACCP | Inhibitor | 97.0% | Unkown |
| HY-147746 | MMP2-IN-3 | Inhibitor | 99.64% | Unkown |
| HY-149848 | MMP-9-IN-6 | Inhibitor | 99.80% | Unkown |
| HY-177701 | MMP-9-IN-13 | Inhibitor | 98.07% | Unkown |
| HY-177990 | STAT3-IN-52 | / | Unkown | |
| HY-B0099S | Edaravone-d5 | 99.76% | Unkown | |
| HY-N2199 | Sotetsuflavone | 96.75% | Unkown | |
| HY-N2205 | Esculentoside H | Inhibitor | 98.73% | Unkown |
| HY-N6860 | Lucidenic acid C | Inhibitor | 99.76% | Unkown |
| HY-P10359A | TAT-QFNP12 acetate | Inhibitor | 95.90% | Unkown |
| HY-P1789A | CTTHWGFTLC, CYCLIC TFA | Inhibitor | 98.52% | Unkown |
| HY-P4373 | Hepcidin-1 (mouse) | Inducer | / | Unkown |
| HY-109747 | RO-28-2653 | Inhibitor | / | Unkown |
| HY-110046 | CL-82198 hydrochloride | Inhibitor | / | Unkown |
| HY-111172 | Inotilone | Inhibitor | 95.26% | Unkown |
| HY-113621B | Ageladine A dihydrochloride | Inhibitor | / | Unkown |
| HY-114091A | PF-00356231 | Inhibitor | / | Unkown |
| HY-114396 | BR351 | Inhibitor | / | Unkown |
| HY-116474R | Viridicatol (Standard) | / | Unkown | |
| HY-119185 | AZD-6605 | / | Unkown | |
| HY-120339 | STK899704 | / | Unkown | |
| HY-12168B | (Rac)-Tanomastat | Inhibitor | / | Unkown |
| HY-123255 | BSc2118 | / | Unkown | |
| HY-124373A | (R)-ND-336 | Inhibitor | / | Unkown |
| HY-136699 | Excisanin A | Inhibitor | / | Unkown |
| HY-138195 | NEO212 | / | Unkown | |
| HY-14237 | SC-77964 | Inhibitor | / | Unkown |
| HY-143407 | FAK-IN-3 | Inhibitor | / | Unkown |
| HY-144224S | Tianeptine-d6 hydrochloride | / | Unkown | |
| HY-146216 | MMP-9-IN-3 | / | Unkown | |
| HY-146217 | MMP-9-IN-4 | / | Unkown | |
| HY-146218 | MMP-9-IN-5 | / | Unkown | |
| HY-14744B | Levamlodipine hydrochloride | Inhibitor | / | Unkown |
| HY-14744C | Levamlodipine hydrobromide | Inhibitor | / | Unkown |
| HY-147867 | MMP-2/9-IN-1 | Inhibitor | / | Unkown |
| HY-152030 | Tubulin/MMP-IN-2 | / | Unkown | |
| HY-153913 | MMP-9-IN-7 | Inhibitor | / | Unkown |
| HY-155721 | 22-(4′-py)-JA | Inhibitor | / | Unkown |
| HY-155960 | SH491 | Inhibitor | / | Unkown |
| HY-156247 | IVMT-Rx-3 | Inhibitor | / | Unkown |
| HY-157138 | MMP-9-IN-8 | / | Unkown | |
| HY-161284 | MMP-9/10-IN-1 | Inhibitor | / | Unkown |
| HY-161707 | MMP2-IN-4 | Inhibitor | / | Unkown |
| HY-161966 | VEGFR-2-IN-52 | / | Unkown | |
| HY-162079 | Anticancer agent 183 | Inhibitor | / | Unkown |
| HY-162344 | Ir-CA | Inducer | / | Unkown |
| HY-163760 | ZM-32 | Inhibitor | / | Unkown |
| HY-168560 | MMP Inhibitor 4 | Inhibitor | / | Unkown |
| HY-168605 | DH-18 | / | Unkown | |
| HY-169062 | RJF02215 | Inhibitor | / | Unkown |
| HY-171776 | OPB-3206 | Inhibitor | / | Unkown |
| HY-172088 | Tubulin/MMP-IN-3 | / | Unkown | |
| HY-172551 | anti-TNBC agent-9 | / | Unkown | |
| HY-173500 | MG-3C | / | Unkown | |
| HY-175275 | 10-Butyl Ether Minocycline | Inhibitor | / | Unkown |
| HY-175558 | MMP-9-IN-12 | / | Unkown | |
| HY-175815 | Apoptosis inducer 44 | / | Unkown | |
| HY-176412 | MMP-9-IN-11 | Inhibitor | / | Unkown |
| HY-178460 | BRK/PTK6-IN-1 | Inhibitor | / | Unkown |
| HY-178477 | LIFR/GPBAR1 modulator 1 | / | Unkown | |
| HY-179439 | Multi-kinase-IN-8 | / | Unkown | |
| HY-179724 | PZ-1657 | Inhibitor | / | Unkown |
| HY-179724A | PZ-1657 hydrochloride | Inhibitor | / | Unkown |
| HY-180117 | MMP-2/9-IN-2 | / | Unkown | |
| HY-180324 | Candidone | / | Unkown | |
| HY-180765 | Colchicine-O-CO-Enyl(Me)-Enyl-Enyl(Me)-Enyl-1,3,3-trimethylcyclohex-1-ene | Activator | / | Unkown |
| HY-181272 | MMP-9-IN-14 | / | Unkown | |
| HY-182069 | CDK9-IN-47 | / | Unkown | |
| HY-182614 | BJ-2302 | Inhibitor | / | Unkown |
| HY-182795 | Colchicine derivative-1 | / | Unkown | |
| HY-182818 | SH494 | / | Unkown | |
| HY-183316 | Anticancer agent 319 | / | Unkown | |
| HY-183784 | P2X7R antagonist-1 | / | Unkown | |
| HY-184162 | HSP110-IN-1 | / | Unkown | |
| HY-18694 | CGS 27023A | Inhibitor | / | Unkown |
| HY-18694A | CGS 27023A free base | Inhibitor | / | Unkown |
| HY-E70617 | Neutrophil Gelatinase Associated Lipocalin (NGAL), Human | / | Unkown | |
| HY-N0757R | 8-O-Acetylharpagide (Standard) | / | Unkown | |
| HY-N10176 | D-Isofloridoside | Inhibitor | 98.59% | Unkown |
| HY-N12726 | Halociline | Inhibitor | / | Unkown |
| HY-N16746 | Nordentatin | Inhibitor | / | Unkown |
| HY-N17617 | S-Petasin | / | Unkown | |
| HY-N2497R | Isoliquiritin apioside (Standard) | Inhibitor | / | Unkown |
| HY-P10359 | TAT-QFNP12 | Inhibitor | / | Unkown |
| HY-P11577 | TGGGPLGVARGKGGC | Substrate | / | Unkown |
| HY-P11780 | KAFDITYVRLKF | / | Unkown | |
| HY-P1789 | CTTHWGFTLC, CYCLIC | Inhibitor | / | Unkown |
| HY-P2004 | FFAGLDD | / | Unkown | |
| HY-P2004A | FFAGLDD TFA | / | Unkown | |
| HY-P3513A | β-Neo-Endorphin acetate | Activator | / | Unkown |
| HY-P3699 | TNO003 | Substrate | / | Unkown |
| HY-P4574 | VPLSLYSG | / | Unkown | |
| HY-RS08559 | Mmp9 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-W095774 | (E)-N-(3-Methoxyphenyl)cinnamamide | Inhibitor | / | Unkown |
| HY-W185542 | E09241 | / | Unkown | |
| HY-W277900 | 2-Methoxy-2,4-diphenylfuran-3-one | / | Unkown | |
| HY-W783478 | Calebin A | Inhibitor | 98.0% | Unkown |
| HY-W801479S | Edaravone sulfate-d5 | / | Unkown | |
| HY-105854A | Pipoxolan | / | Unkown | |
| HY-107581R | MK-1903 (Standard) | / | Unkown | |
| HY-112726A | PXS-4728A free base | Inhibitor | / | Unkown |
| HY-119110 | LY52 | Inhibitor | / | Unkown |
| HY-122585 | proMMP-9 inhibitor-3c | Inhibitor | / | Unkown |
| HY-124068 | LQB-118 | / | Unkown | |
| HY-133845 | CIL-102 | / | Unkown | |
| HY-14744D | Levamlodipine besylate Hemipentahydrate | Inhibitor | / | Unkown |
| HY-14744S | Levamlodipine-d4 | Inhibitor | 99.74% | Unkown |
| HY-164525 | SD-7300 | Inhibitor | / | Unkown |
| HY-183400 | BIM-46174 | / | Unkown | |
| HY-35513 | 3-Aminobenzene-1,2-diol | Inhibitor | 98.0% | Unkown |
| HY-43586 | BR351 precursor | Inhibitor | / | Unkown |
| HY-90003S | Tianeptine-d12 | / | Unkown | |
| HY-B1451S | Imidapril-d3 hydrochloride | Inhibitor | / | Unkown |
| HY-P3699A | TNO003 TFA | Substrate | / | Unkown |
| HY-W747703 | Hippuric acid-13C6 | / | Unkown | |
| HY-P0273 | Histatin 5 | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(2)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P992200 | Anti-CD146 Antibody (AA98) | / | Unkown | |
| HY-P990468 | Anti-MMP9 Antibody | Inhibitor | / | Unkown |